90 related articles for article (PubMed ID: 6747829)
1. Stereoselective metabolism and pharmacogenetic control of 5-phenyl-5-ethylhydantoin (nirvanol) in humans.
Küpfer A; Patwardhan R; Ward S; Schenker S; Preisig R; Branch RA
J Pharmacol Exp Ther; 1984 Jul; 230(1):28-33. PubMed ID: 6747829
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic differences in mephenytoin pharmacokinetics in normal subjects.
Wedlund PJ; Aslanian WS; Jacqz E; McAllister CB; Branch RA; Wilkinson GR
J Pharmacol Exp Ther; 1985 Sep; 234(3):662-9. PubMed ID: 4032286
[TBL] [Abstract][Full Text] [Related]
3. Mephenytoin hydroxylation deficiency: kinetics after repeated doses.
Küpfer A; Desmond P; Patwardhan R; Schenker S; Branch RA
Clin Pharmacol Ther; 1984 Jan; 35(1):33-9. PubMed ID: 6690169
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective metabolism, pharmacokinetics and biliary elimination of phenylethylhydantoin (Nirvanol) in the dog.
Küpfer A; Bircher J; Preisig R
J Pharmacol Exp Ther; 1977 Dec; 203(3):493-9. PubMed ID: 925954
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of R-enantiomeric normephenytoin during chronic administration in epileptic patients.
Bourgeois BF; Küpfer A; Wad N; Egli M
Epilepsia; 1986; 27(4):412-8. PubMed ID: 3720699
[TBL] [Abstract][Full Text] [Related]
6. Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylation.
Küpfer A; Branch RA
Clin Pharmacol Ther; 1985 Oct; 38(4):414-8. PubMed ID: 4042524
[TBL] [Abstract][Full Text] [Related]
7. A major pathway of mephenytoin metabolism in man. Aromatic hydroxylation to p-hydroxymephenytoin.
Küpfer A; Brilis GM; Watson JT; Harris TM
Drug Metab Dispos; 1980; 8(1):1-4. PubMed ID: 6102023
[TBL] [Abstract][Full Text] [Related]
8. Direct enantiomeric resolution of mephenytoin and its N-demethylated metabolite in plasma and blood using chiral capillary gas chromatography.
Wedlund PJ; Sweetman BJ; McAllister CB; Branch RA; Wilkinson GR
J Chromatogr; 1984 Apr; 307(1):121-7. PubMed ID: 6725478
[TBL] [Abstract][Full Text] [Related]
9. Stereoselectivity of the arene epoxide pathway of mephenytoin hydroxylation in man.
Küpfer A; Lawson J; Branch RA
Epilepsia; 1984 Feb; 25(1):1-7. PubMed ID: 6420144
[TBL] [Abstract][Full Text] [Related]
10. Stereochemical aspects of the metabolism of 5-ethyl-5-phenylhydantoin (Nirvanol) in the dog.
Maguire JH; Kraus BL; Butler TC; Dudley KH
Drug Metab Dispos; 1981; 9(5):393-401. PubMed ID: 6117436
[TBL] [Abstract][Full Text] [Related]
11. Stereochemistry of aromatic phenytoin hydroxylation in various drug hydroxylation phenotypes in humans.
Fritz S; Lindner W; Roots I; Frey BM; Küpfer A
J Pharmacol Exp Ther; 1987 May; 241(2):615-22. PubMed ID: 3572817
[TBL] [Abstract][Full Text] [Related]
12. S-mephenytoin hydroxylation phenotypes in a Jordanian population.
Hadidi HF; Irshaid YM; Woosley RL; Idle JR; Flockhart DA
Clin Pharmacol Ther; 1995 Nov; 58(5):542-7. PubMed ID: 7586948
[TBL] [Abstract][Full Text] [Related]
13. Oxidative metabolism of hexobarbital in human liver: relationship to polymorphic S-mephenytoin 4-hydroxylation.
Knodell RG; Dubey RK; Wilkinson GR; Guengerich FP
J Pharmacol Exp Ther; 1988 Jun; 245(3):845-9. PubMed ID: 3385644
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics of mephenytoin: a new drug hydroxylation polymorphism in man.
Küpfer A; Preisig R
Eur J Clin Pharmacol; 1984; 26(6):753-9. PubMed ID: 6489416
[TBL] [Abstract][Full Text] [Related]
15. Enantiospecific separation and quantitation of mephenytoin and its metabolites nirvanol and 4'-hydroxymephenytoin in human plasma and urine by liquid chromatography/tandem mass spectrometry.
Jansson B; Elsherbiny D; Simonsson US
Rapid Commun Mass Spectrom; 2006; 20(3):463-72. PubMed ID: 16395737
[TBL] [Abstract][Full Text] [Related]
16. The N-demethylation of imipramine correlates with the oxidation of S-mephenytoin (S/R-ratio). A population study.
Skjelbo E; Gram LF; Brøsen K
Br J Clin Pharmacol; 1993 Mar; 35(3):331-4. PubMed ID: 8471415
[TBL] [Abstract][Full Text] [Related]
17. Relation of in vivo drug metabolism to stereoselective fetal hydantoin toxicology in mouse: evaluation of mephenytoin and its metabolite, nirvanol.
Wells PG; Küpfer A; Lawson JA; Harbison RD
J Pharmacol Exp Ther; 1982 Apr; 221(1):228-34. PubMed ID: 7062285
[TBL] [Abstract][Full Text] [Related]
18. Stereoselective metabolism and disposition of the enantiomers of mephenytoin during chronic oral administration of the racemic drug in man.
Küpfer A; Desmond PV; Schenker S; Branch RA
J Pharmacol Exp Ther; 1982 Jun; 221(3):590-7. PubMed ID: 7086673
[No Abstract] [Full Text] [Related]
19. Assay of mephenytoin metabolism in human liver microsomes by high-performance liquid chromatography.
Meier UT; Kronbach T; Meyer UA
Anal Biochem; 1985 Dec; 151(2):286-91. PubMed ID: 4096368
[TBL] [Abstract][Full Text] [Related]
20. Analysis of mephenytoin, 4-hydroxymephenytoin and 4-hydroxyphenytoin enantiomers in human urine by cyclodextrin micellar electrokinetic capillary chromatography: simple determination of a hydroxylation polymorphism in man.
Desiderio C; Fanali S; Küpfer A; Thormann W
Electrophoresis; 1994 Jan; 15(1):87-93. PubMed ID: 8143685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
